Cyclin alterations in giant cell tumor of bone

Modern Pathology

Volumn 16, Issue 3, 2003, Pages 210-218

  Kauzman, Adel ^a,c   Li, Shu Qiu ^a   Bradley, Grace ^c   Bell, Robert S ^b   Wunder, Jay S ^b   Kandel, Rita ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cyclin B1; Cyclin D1; Cyclin D3; Gene amplification; Giant cell tumor of bone; Immunohistochemistry; Ki 67

Indexed keywords

CYCLIN B1; CYCLIN D1; CYCLIN D3; CYCLINE; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CELL CYCLE; CELL DIVISION; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LONG BONE; MALE; MONONUCLEAR CELL; OSTEOCLASTOMA; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CYCLIN B; CYCLIN D1; CYCLINS; FEMALE; GENE AMPLIFICATION; GIANT CELL TUMOR OF BONE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 0037339796     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000057235.65327.40     Document Type: Article

References (53)

1. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999;13:1501-12.
2. Mittnacht S. Control of pRB phosphorylation. Curr Opin Genet Dev 1998;8:21-7.
3. Sherr CJ. Cancer cell cycles. Science 1996;274:1672-7.
4. Ekholm SV, Reed SI. Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Curr Opin Cell Biol 2000;12:676-84.
5. Lukas J, Muller H, Bartkova J, et al. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J Cell Biol 1994;125:625-38.
6. Resnitzky D, Gossen M, Bujard H, Reed SI. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 1994;14:1669-79.
7. Liu SC, Klein-Szanto AJ. Markers of proliferation in normal and leukoplakic oral epithelia. Oral Oncol 2000;36:145-51.
8. Bartek J, Bartkova J, Lukas J. The retinoblastoma protein pathway in cell cycle control and cancer. Exp Cell Res 1997;237:1-6.
9. Lukas J, Aagaard L, Strauss M, Bartek J. Oncogenic aberrations of p161NK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control. Cancer Res 1995;55:4818-23.
10. Bodrug SE, Warner BJ, Bath ML, et al. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 1994;13:2124-30.
11. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci U S A 1994;91:709-13.
12. Lee RJ, Albanese C, Fu M, et al. Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway. Mol Cell Biol 2000;20:672-83.
13. Wang TC, Cardiff RD, Zukerberg L, et al. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 1994;369:669-71.
14. Donnellan R, Chetty R. Cyclin D1 and human neoplasia. Mol Pathol 1998;51:1-7.
15. Zhu XL, Hartwick W, Rohan T, Kandel R. Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma. Mod Pathol 1998;11:1082-8.
16. Rousseau A, Lim MS, Lin Z, Jordan RC. Frequent cyclin D1 gene amplification and protein overexpression in oral epithelial dysplasias. Oral Oncol 2001;37:268-75.
17. Capaccio P, Pruneri G, Carboni N, et al. Cyclin D1 protein expression is related to clinical progression in laryngeal squamous cell carcinomas. J Laryngol Otol 1997;111:622-6.
18. Jackman M, Firth M, Pines J. Human cyclins B1 and B2 are localized to strikingly different structures: B1 to microtubules, B2 primarily to the Golgi apparatus. EMBO J 1995;14:1646-54.
19. Brandeis M, Rosewell I, Carrington M, et al. Cyclin B2-null mice develop normally and are fertile whereas cyclin B1-null mice die in utero. Proc Natl Acad Sci U S A 1998;95:4344-9.
20. Yang J, Bardes ES, Moore JD, et al. Control of cyclin B1 localization through regulated binding of the nuclear export factor CRM1. Genes Dev 1998;12:2131-43.
21. Soria JC, Jang SJ, Khuri FR, et al. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res 2000;60:4000-4.
22. Kawamoto H, Koizumi H, Uchikoshi T. Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses. Am J Pathol 1997;150:15-23.
23. Wang A, Yoshimi N, Ino N, Tanaka T, Mori H. Overexpression of cyclin B1 in human colorectal cancers. J Cancer Res Clin Oncol 1997;123:124-7.
24. Mashal RD, Lester S, Corless C, et al. Expression of cell cycle-regulated proteins in prostate cancer, Cancer Res 1996;56:4159-63.
25. Kushner J, Bradley G, Young B, Jordan RC. Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma. J Oral Pathol Med 1999;28:77-81.
26. Murakami H, Furihata M, Ohtsuki Y, Ogoshi S. Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma. Virchows Arch 1999;434:153-8.
27. Hassan KA, El-Naggar AK, Soria JC, et al. Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue. Clin Cancer Res 2001;7:2458-62.
28. Dorfman HD, Bogdan C, editors. Bone tumors. 1st ed. Toronto: Mosby, Inc.; 1998.
29. Masui F, Ushigome S, Fujii K. Giant cell tumor of bone: a clinicopathologic study of prognostic factors. Pathol Int 1998;48:723-9.
30. Masui F, Ushigome S, Fujii K. Giant cell tumor of bone: an immunohistochemical comparative study. Pathol Int 1998;48:355-61.
31. Sulh MA, Greco MA, Jiang T, et al. Proliferation index and vascular density of giant cell tumors of bone: are they prognostic markers? Cancer 1996;77:2044-51.
32. Scotlandi K, Serra M, Manara MC, et al. Clinical relevance of Ki-67 expression in bone tumors. Cancer 1995;75:806-14.
33. Antal I, Sapi Z, Szendroi M. The prognostic significance of DNA cytophotometry and proliferation index (Ki-67) in giant cell tumors of bone. Int Orthop 1999;23:315-9.
34. Bartkova J, Lukas J, Muller H, et al. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 1994;57:353-61.
35. Lammie GA, Fantl V, Smith R, et al. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 1991;6:439-44.
36. Buckley MF, Sweeney KJ, Hamilton JA, et al. Expression and amplification of cyclin genes in human breast cancer. Oncogene 1993;8:2127-33.
37. Gramlich TL, Fritsch CR, Maurer D, Eberle M, Gansler TS. Differential polymerase chain reaction assay of cyclin D1 gene amplification in esophageal carcinoma. Diagn Mol Pathol 1994;3:255-9.
38. Suzuki H, Moriya J, Nakahata A, et al. Cyclin D1 gene amplification in esophageal carcinosarcoma shown by differential polymerase chain reaction. Hum Pathol 1998;29:662-7.
39. Neubauer A, Neubauer B, He M, et al. Analysis of gene amplification in archival tissue by differential polymerase chain reaction. Oncogene 1992;7:1019-25.
40. Zukerberg LR, Yang WI, Gadd M, et al. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Mod Pathol 1995;8:560-7.
41. Frierson HF Jr, Gaffey MJ, Zukerberg LR, Arnold A, Williams ME. Immunohistochemical detection and gene amplification of cyclin D1 in mammary infiltrating ductal carcinoma. Mod Pathol 1996;9:725-30.
42. Gaffey MJ, Iezzoni JC, Meredith SD, et al. Cyclin D1 (PRAD1, CCND1) and glutathione-S-transferase pi gene expression in head and neck squamous cell carcinoma. Hum Pathol 1995;26:1221-6.
43. Sola B, Salaun V, Ballet JJ, Troussard X. Transcriptional and post-transcriptional mechanisms induce cyclin-D1 overexpression in B-chronic lymphoproliferative disorders. Int J Cancer 1999;83:230-4.
44. Daksis JI, Lu RY, Facchini LM, Marhin WW, Penn LJ. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene 1994;9:3635-45.
45. Diehl JA, Zindy F, Sherr CJ. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev 1997;11:957-72.
46. Takuwa N, Fukui Y, Takuwa Y. Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70 (S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts. Mol Cell Biol 1999;19:1346-58.
47. Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998;12:3499-511.
48. Soonpaa MH, Koh GY, Pajak L, et al. Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice. J Clin Invest 1997;99:2644-54.
49. Palazon LS, Davies TJ, Gardner RL. Translational inhibition of cyclin B1 and appearance of cyclin D1 very early in the differentiation of mouse trophoblast giant cells. Mol Hum Reprod 1998;4:1013-20.
50. Sun S, Zimmet JM, Toselli P, et al. Overexpression of cyclin D1 moderately increases ploidy in megakaryocytes. Haematologica 2001;86:17-23.
51. Wang Z, Zhang Y, Kamen D, Lees E, Ravid K. Cyclin D3 is essential for megakaryocytopoiesis. Blood 1995;86:3783-8.
52. Grano M, Colucci S, De Bellis M, et al. New model for bone resorption study in vitro: human osteoclast-like cells from giant cell tumors of bone. J Bone Miner Res 1994;9:1013-20.
53. Pellegrini W, Facchetti F, Marocolo D, et al. Assessment of cell proliferation in normal and pathological bone marrow biopsies: a study using double sequential immunophenotyping on paraffin sections. Histopathology 1995;27:397-405.